Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in Alzheimer's disease efficacy trial: The MADE trial
2013-000397-30Phase 2Completed
- Sponsor
- King's College London
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing minocycline with placebo (2 arms). Primary endpoint: Cognitive function. Started Jun 2013; status: completed.
02
Drugs
minocycline
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2013-000397-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000397-30.